mammaprint.com.au

Breast Cancer Diagnosis Treatment | Mammaprint | Associate Professor Guy Hingston

Breast cancer patients could be. Spared chemotherapy with new. Genetic test, study shows. Targeted Breast Cancer Medical. Treatment Now A Reality. Breast Cancer Subgroup Unlikely. To Benefit From Adjuvant Chemo. 038; BluePrint Test. MSAC – MammaPrint DAP. Profile Pricing and Payment. Breast cancer patients could be. Spared chemotherapy with new. Genetic test, study shows. Targeted Breast Cancer Medical. Treatment Now A Reality. Breast Cancer Subgroup Unlikely. To Benefit From Adjuvant Chemo. MammaPrint i...

http://mammaprint.com.au/

OVERVIEW OF mammaprint.com.au

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

19

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR MAMMAPRINT.COM.AU

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

May

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Thursday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 4.6 out of 5 with 7 reviews

5 star

4

4 star

3

3 star

0

2 star

0

1 star

0

Hey there! Start your review of mammaprint.com.au

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

5.1 seconds

FAVICON PREVIEW

16x16
32x32

CONTACTS AT MAMMAPRINT.COM.AU

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

PAGES IN
THIS WEBSITE

19

SSL

EXTERNAL LINKS

13

SITE IP

162.144.42.245

LOAD TIME

5.141 sec

SCORE

6.2

PAGE TITLE

Breast Cancer Diagnosis Treatment | Mammaprint | Associate Professor Guy Hingston | mammaprint.com.au Reviews

<META> DESCRIPTION

Breast cancer patients could be. Spared chemotherapy with new. Genetic test, study shows. Targeted Breast Cancer Medical. Treatment Now A Reality. Breast Cancer Subgroup Unlikely. To Benefit From Adjuvant Chemo. 038; BluePrint Test. MSAC – MammaPrint DAP. Profile Pricing and Payment. Breast cancer patients could be. Spared chemotherapy with new. Genetic test, study shows. Targeted Breast Cancer Medical. Treatment Now A Reality. Breast Cancer Subgroup Unlikely. To Benefit From Adjuvant Chemo. MammaPrint i...

<META> KEYWORDS

1 menu

2 news

3 mindact is out

4 70 gene signature identifies

5 agendia’s mammaprint

6 agendia genomic tests

7 press releases

8 about us

9 genome investigation

10 agendia

CONTENT

Page content here

KEYWORDS ON PAGE

menu,news,mindact is out,70 gene signature identifies,agendia’s mammaprint,agendia genomic tests,press releases,about us,genome investigation,agendia,patients,about mammaprint,do i qualify,question and answer,the right treatment,tested and approved

SERVER

Apache

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

Breast Cancer Diagnosis Treatment | Mammaprint | Associate Professor Guy Hingston | mammaprint.com.au Reviews

https://mammaprint.com.au

Breast cancer patients could be. Spared chemotherapy with new. Genetic test, study shows. Targeted Breast Cancer Medical. Treatment Now A Reality. Breast Cancer Subgroup Unlikely. To Benefit From Adjuvant Chemo. 038; BluePrint Test. MSAC – MammaPrint DAP. Profile Pricing and Payment. Breast cancer patients could be. Spared chemotherapy with new. Genetic test, study shows. Targeted Breast Cancer Medical. Treatment Now A Reality. Breast Cancer Subgroup Unlikely. To Benefit From Adjuvant Chemo. MammaPrint i...

INTERNAL PAGES

mammaprint.com.au

1

MSAC – MammaPrint DAP | Breast Cancer Diagnosis Treatment

http://www.mammaprint.com.au/msac-mammaprint-dap

Breast cancer patients could be. Spared chemotherapy with new. Genetic test, study shows. Targeted Breast Cancer Medical. Treatment Now A Reality. Breast Cancer Subgroup Unlikely. To Benefit From Adjuvant Chemo. 038; BluePrint Test. MSAC – MammaPrint DAP. Profile Pricing and Payment. Breast cancer patients could be. Spared chemotherapy with new. Genetic test, study shows. Targeted Breast Cancer Medical. Treatment Now A Reality. Breast Cancer Subgroup Unlikely. To Benefit From Adjuvant Chemo.

2

Agendia Genomic Tests | Breast Cancer Diagnosis Treatment

http://www.mammaprint.com.au/agendia-genomic-tests

Breast cancer patients could be. Spared chemotherapy with new. Genetic test, study shows. Targeted Breast Cancer Medical. Treatment Now A Reality. Breast Cancer Subgroup Unlikely. To Benefit From Adjuvant Chemo. 038; BluePrint Test. MSAC – MammaPrint DAP. Profile Pricing and Payment. Breast cancer patients could be. Spared chemotherapy with new. Genetic test, study shows. Targeted Breast Cancer Medical. Treatment Now A Reality. Breast Cancer Subgroup Unlikely. To Benefit From Adjuvant Chemo. Agendia’s Bl...

3

Patient Eligibility | Breast Cancer Diagnosis Treatment

http://www.mammaprint.com.au/patients-eligibility

Breast cancer patients could be. Spared chemotherapy with new. Genetic test, study shows. Targeted Breast Cancer Medical. Treatment Now A Reality. Breast Cancer Subgroup Unlikely. To Benefit From Adjuvant Chemo. 038; BluePrint Test. MSAC – MammaPrint DAP. Profile Pricing and Payment. Breast cancer patients could be. Spared chemotherapy with new. Genetic test, study shows. Targeted Breast Cancer Medical. Treatment Now A Reality. Breast Cancer Subgroup Unlikely. To Benefit From Adjuvant Chemo. MammaPrint p...

4

Tested and approved | Breast Cancer Diagnosis Treatment

http://www.mammaprint.com.au/tested-and-approved

Breast cancer patients could be. Spared chemotherapy with new. Genetic test, study shows. Targeted Breast Cancer Medical. Treatment Now A Reality. Breast Cancer Subgroup Unlikely. To Benefit From Adjuvant Chemo. 038; BluePrint Test. MSAC – MammaPrint DAP. Profile Pricing and Payment. Breast cancer patients could be. Spared chemotherapy with new. Genetic test, study shows. Targeted Breast Cancer Medical. Treatment Now A Reality. Breast Cancer Subgroup Unlikely. To Benefit From Adjuvant Chemo. This was a m...

5

Press Releases | Breast Cancer Diagnosis Treatment

http://www.mammaprint.com.au/press-releases

Breast cancer patients could be. Spared chemotherapy with new. Genetic test, study shows. Targeted Breast Cancer Medical. Treatment Now A Reality. Breast Cancer Subgroup Unlikely. To Benefit From Adjuvant Chemo. 038; BluePrint Test. MSAC – MammaPrint DAP. Profile Pricing and Payment. Breast cancer patients could be. Spared chemotherapy with new. Genetic test, study shows. Targeted Breast Cancer Medical. Treatment Now A Reality. Breast Cancer Subgroup Unlikely. To Benefit From Adjuvant Chemo. MammaPrint i...

UPGRADE TO PREMIUM TO VIEW 14 MORE

TOTAL PAGES IN THIS WEBSITE

19

LINKS TO THIS WEBSITE

drguy.com.au

Associate Professor Guy Hingston | Associate Professor Guy Hingston | Cancer Surgeon, Author & Health Speaker

https://www.drguy.com.au/about

Associate Professor Guy Hingston. Associate Professor Guy Hingston is a respected surgical oncologist, author and speaker. He has a passionate interest in preventive health and travels speaking and lecturing on this topic to business people, schools, medical colleagues and other groups. His powerful message is drawn from his many years’ experience as a surgical oncologist who has specialised in breast reduction and reconstructive surgery. Guy recently published two health service manuals -. In 2003, Guy ...

drguy.com.au

Publications | Associate Professor Guy Hingston | Cancer Surgeon, Author & Health Speaker

https://www.drguy.com.au/publications

Over five years on, we still don’t need a bowel cancer screening programme: Please just get on with it! Guy Hingston NZMJ 2015 Dec (128):1426, 113-115. MammaPrint Decision Analytic Protocol for Medical Services Advisory Committee. See http:/ www.msac.gov.au/internet/msac/publishing.nsf/Content/1376-public. 70 gene risk stratification, 80 gene molecular subtyping and 3 gene receptor analysis via mRNA microarray breast cancer genomic testing. Guy Hingston, Stephen Begbie, Carla Gillespie. Br J Surg. 19...

drguy.com.au

Testimonials | Associate Professor Guy Hingston | Cancer Surgeon, Author & Health Speaker

https://www.drguy.com.au/testimonials

Click image to view. Dr Guy has recently been a key speaker at our ‘Medicine with Altitude’ conferences in Whistler (Canada), Chamonix (France) and Wanaka (New Zealand). He was very well received with a most informative presentation. Preventative health is essential to good medicine and Dr Guy delivers a concept of regular evidence based interventions and lifestyle advice with passion and clear scientific rigor. Dr Richard Abbott MBBS FRACGP. Medicine with Altitude Conference Director. 8220;I have been f...

drguy.com.au

Store | Associate Professor Guy Hingston | Cancer Surgeon, Author & Health Speaker

https://www.drguy.com.au/store

Men s Service Manual for Life $29.95. Women s Service Manual for Life $29.95. Content by Guy Hingston. Web Design by Designmonger Managed by Benn Web Design and Marketing.

drguy.com.au

Speaking Topics | Associate Professor Guy Hingston | Cancer Surgeon, Author & Health Speaker

https://www.drguy.com.au/speaking-topics

Click image to view. Re-Thinking Preventive Health in 2016 and Beyond. What’s Likely to Take You Out? Current Cancer Trends in Australia. Breast Reduction Surgery for Those in Need. Providing Health Care for the ADF in the Solomon Islands. Breast & Bowel Cancer Screening: Are they life savers? How you can benefit from a new preventive health tool. Content by Guy Hingston. Web Design by Designmonger Managed by Benn Web Design and Marketing.

drguy.com.au

Links | Associate Professor Guy Hingston | Cancer Surgeon, Author & Health Speaker

https://www.drguy.com.au/links

National Breast Cancer Foundation. Fellow of Royal Royal Australian College of Surgeons. Royal Australian College of Surgeons. Content by Guy Hingston. Web Design by Designmonger Managed by Benn Web Design and Marketing.

gold-book.net

News | Gold Book

http://www.gold-book.net/news

The Gold Book for Men. Preventing the Early Demise of 20,000 Aussies each year. The Gold Book for Women. The Gold Book for Men. The Gold Book for Women. Associate Professor Guy Hingston. Getting serious about preventive health. Follow Dr Guy on. Targeted Breast Cancer Medical Treatment Now A Reality MINDACT is Out! More information about MINDACT and MammaPrint testing can be obtained online at www.mammaprint.com.au. Article by Wayne Kuznar. In the study known as MINDACT, patients deemed high risk clinica...

drguy.com.au

References | Associate Professor Guy Hingston | Cancer Surgeon, Author & Health Speaker

https://www.drguy.com.au/references

Australian National Preventive Health Agency. The Royal Australian College of General Practitioners Guidelines. The Australian Government National Health and Research Council Health Guidelines. The 2010 Australian National Immunisation Program Schedule. National Guide to a preventative assessment in Aboriginal and Torres Strait Islander peoples. Adult preventive health life cycle summary chart. Cancer in Australia: An Overview 2008 (AIHW). Australian Cancer Incidence and Mortality (ACIM).

agendia.com

International | Agendia

http://www.agendia.com/international

Ordering & Client Login. Awards & Recognition. Accreditations & Licenses. Investors & Press. News and Press Releases. Please select a country below to see our international websites. We'd Love To Hear From You. Questions, Comments, Concerns? Questions, Comments, Concerns? This field is for validation purposes and should be left unchanged. This iframe contains the logic required to handle AJAX powered Gravity Forms. Investors & Press. Accreditations & Licenses. Irvine, CA 92618. 31 (0)20 462 1500.

UPGRADE TO PREMIUM TO VIEW 4 MORE

TOTAL LINKS TO THIS WEBSITE

13

OTHER SITES

mammaprint.at

SiteGround Web Hosting Server Default Page

Website currently not available. Nice of you to come by, but currently this web page is feeling a bit under the weather. Why not check back later? If you're the owner of this website , here are some possible explanations why you're seeing this page:. If you purchased a new domain, its DNS may not be pointed correctly. Click here to learn more. Then you might have to wait a while until they propagate. Click here to learn more. If so, you should allow some time for the change to propagate.

mammaprint.be

MammaPrint - alles over MammaPrint

Nu contact met Agendia? Of bel: 0031 20 462 1510. MammaPrint maakt iedere behandeling uniek. Zojuist hebt u de diagnose gehoord: borstkanker. Maar wat is de volgende stap? Helaas krijgt 1 op de 2 borstkankerpatiëntes onnodig chemotherapie. MammaPrint is uniek. Het is de enige test die uw tumor precies in kaart brengt, zodat u en uw arts preciezer kunnen bepalen welke behandeling het beste bij uw situatie past. MammaPrint meet de mRNA hoeveelheid van 1900 verschillende genen. Daarbij wordt extra gekek...

mammaprint.co.nz

Breast Cancer Diagnosis Treatment | Mammaprint | Associate Professor Guy Hingston

Breast cancer patients could be. Spared chemotherapy with new. Genetic test, study shows. Targeted Breast Cancer Medical. Treatment Now A Reality. Breast Cancer Subgroup Unlikely. To Benefit From Adjuvant Chemo. 038; BluePrint Test. Profile Pricing and Payment. Breast cancer patients could be. Spared chemotherapy with new. Genetic test, study shows. Targeted Breast Cancer Medical. Treatment Now A Reality. Breast Cancer Subgroup Unlikely. To Benefit From Adjuvant Chemo. 038; BluePrint Test. Where a histol...

mammaprint.co.uk

MammaPrint - MammaPrint - everything you need to know about MammaPrint

Do you wish to contact Agendia dial 0031 20 462 1510 or or e-mail. MammaPrint makes every treatment unique. You have just been diagnosed with breast cancer. But what is the next step? Unfortunately, half of all breast cancer patients receive chemotherapy unnecessarily. MammaPrint is unique. It is the only test which can indicate with precision which stage your tumour is at, so that you and your physician can decide on the most appropriate treatment for your condition. How does MammaPrint work? MammaPrint...

mammaprint.com

SiteGround Web Hosting Server Default Page

Website currently not available. Nice of you to come by, but currently this web page is feeling a bit under the weather. Why not check back later? If you're the owner of this website , here are some possible explanations why you're seeing this page:. If you purchased a new domain, its DNS may not be pointed correctly. Click here to learn more. Then you might have to wait a while until they propagate. Click here to learn more. If so, you should allow some time for the change to propagate.

mammaprint.com.au

Breast Cancer Diagnosis Treatment | Mammaprint | Associate Professor Guy Hingston

Breast cancer patients could be. Spared chemotherapy with new. Genetic test, study shows. Targeted Breast Cancer Medical. Treatment Now A Reality. Breast Cancer Subgroup Unlikely. To Benefit From Adjuvant Chemo. 038; BluePrint Test. MSAC – MammaPrint DAP. Profile Pricing and Payment. Breast cancer patients could be. Spared chemotherapy with new. Genetic test, study shows. Targeted Breast Cancer Medical. Treatment Now A Reality. Breast Cancer Subgroup Unlikely. To Benefit From Adjuvant Chemo. MammaPrint i...

mammaprint.com.mx

Mammaprint

mammaprint.de

MammaPrint - alles über MammaPrint

Wollen Sie mit Agendia in Kontakt treten? Oder Anruf: Deutschland: 0800-0061950, Schweiz und Österreich: 0800-006195. MammaPrint macht jede Behandlung einzigartig. Soeben haben Sie die Diagnose gehört: Brustkrebs. Aber was ist jetzt der nächste Schritt? MammaPrint ist ein Test von Agendia, mit dem die Aggressivität eines Brusttumors bestimmt werden kann. Aufgrund des Testergebnisses von MammaPrint kann Ihr behandelnder Arzt die Entscheidung treffen, welche Behandlung nach der Operation die beste ist.

mammaprint.fr

MammaPrint - Tout sur MammaPrint

Vous souhaitez prendre contact avec Agendia? Ou téléphonez au 0031 20 462 1510. MammaPrint fait de chaque traitement un traitement unique. Vous venez d apprendre le diagnostic: vous avez un cancer du sein. Mais que faire maintenant? MammaPrint est un test d Agendia qui détermine l agressivité d une tumeur du sein. Sur base des résultats de MammaPrint, le médecin qui vous traite pourra déterminer quel est le meilleur traitement après l opération. Comment fonctionne le MammaPrint? Le MammaPrint mesure la q...

mammaprint.it

MammaPrint - sviluppato da una donna per le donne

Vuoi contattare Agendia ora? O chiama il numero verde 800974122. MammaPrint: sviluppato da una donna per le donne. Ciò che più mi ha convinto a portare MammaPrint alla comunità medica è il reale beneficio che il test è in grado di dare alle donne colpite da cancro al seno. MammaPrint fornisce alle pazienti e ai loro medici informazioni più accurate sul rischio individuale di recidiva e consente di fare scelte terapeutiche più informate e personalizzate. MammaPrint rende unico ogni tipo di trattamento.

mammaprint.nl

Home | MammaPrint en BluePrint

Diagnose borstkanker, wat nu? Agendia testen voor borstkanker. Risico-inschatting van uitzaaiingen bij borstkanker. Volgende stap na de diagnose borstkanker. De diagnose borstkanker brengt veel onzekerheid en vragen met zich mee. MammaPrint is een borstkankertest die een grote groep patiënten kan helpen beslissen of chemotherapie noodzakelijk is voor de juiste behandeling. Hoog of laag risico? Hoe groot is de kans dat de tumor weer terugkomt? BORSTKANKER, WAT NU? Nu contact met Agendia?